These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2841208)

  • 1. Occurrence of CA 125 and CA 19-9 tumor-associated antigens in sera of patients with gynecologic, trophoblastic, and colorectal tumors.
    Göcze PM; Szabó DG; Than GN; Csaba IF; Krommer KF
    Gynecol Obstet Invest; 1988; 25(4):268-72. PubMed ID: 2841208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of serum sialosyl-Tn antigen levels in comparison with CA 125 levels in gynecologic cancers.
    Ryuko K; Iwanari O; Nakayama S; Iida K; Kitao M
    Cancer; 1992 May; 69(9):2368-78. PubMed ID: 1562985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pros and cons of gynecologic tumor markers.
    Bast RC; Hunter V; Knapp RC
    Cancer; 1987 Oct; 60(8 Suppl):1984-92. PubMed ID: 2443235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor antigens CA 125 and CA l9-9 in the serum of patients with gynecologic trophoblastic tumors and colorectal carcinoma].
    Göcze P; Szabó D; Than G; Csaba I; Krommer K
    Orv Hetil; 1986 Aug; 127(35):2123-6. PubMed ID: 3024089
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum-SP1-pregnancy-specific-beta-glycoprotein in choriocarcinoma and other neoplastic disease.
    Searle F; Leake BA; Bagshawe KD; Dent J
    Lancet; 1978 Mar; 1(8064):579-81. PubMed ID: 76123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical value of the tumor markers CA 19/9 and carcinoembryonic antigen (CEA) in colorectal carcinomas: a critical comparison.
    von Kleist S
    Int J Biol Markers; 1986; 1(1):3-8. PubMed ID: 3480321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular heterogeneity of hCGbeta--related glycoproteins and the clinical relevance in trophoblastic and non-trophoblastic tumors.
    Nishimura R; Koizumi T; Yokotani T; Taniguchi R; Morisue K; Yoshimura M; Hiranmoy D; Yamaguchi S; Nakagawa T; Hasegawa K; Yasui H
    Int J Gynaecol Obstet; 1998 Apr; 60 Suppl 1():S29-32. PubMed ID: 9833612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of four serum tumour markers in the diagnosis of colorectal carcinoma.
    van der Schouw YT; Verbeek AL; Wobbes T; Segers MF; Thomas CM
    Br J Cancer; 1992 Jul; 66(1):148-54. PubMed ID: 1379057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnostic significance of tumor markers for gynecologic malignancies].
    Aoki D; Hirasawa A; Susumu N
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):411-6. PubMed ID: 15791829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum sialyl-Tn antigen levels in patients with digestive cancers.
    Motoo Y; Kawakami H; Watanabe H; Satomura Y; Ohta H; Okai T; Makino H; Toya D; Sawabu N
    Oncology; 1991; 48(4):321-6. PubMed ID: 1891175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Major basic protein as a marker of malignant potential in trophoblastic neoplasia.
    Gurian KV; Podratz KC; Elg SA; Twiggs LB; Lurain JR; Wagner JM; Gleich GJ
    Am J Obstet Gynecol; 1996 Sep; 175(3 Pt 1):632-7. PubMed ID: 8828426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of sialyl Tn antigen in patients with gynecologic tumors.
    Inoue M; Ogawa H; Nakanishi K; Tanizawa O; Karino K; Endo J
    Obstet Gynecol; 1990 Jun; 75(6):1032-6. PubMed ID: 2342728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CA-50 as a tumour marker for monitoring colorectal cancer: antigen rises in patients postoperatively precede clinical manifestations of recurrence.
    Persson BE; Ståhle E; Påhlman L; Glimelius B; Holmgren J
    Eur J Cancer Clin Oncol; 1988 Feb; 24(2):241-6. PubMed ID: 2451612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical use of gynaecologic tumour markers.
    Halila H; Alfthan H; Stenman UH
    Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers in gynaecological cancer.
    Farrell RJ
    Ir Med J; 1980 Aug; 73(8):285-6. PubMed ID: 6161106
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of tumor markers in the diagnosis and treatment monitoring of malignant tumors of the female genitalia].
    Seliuzhitskiĭ IV; Skvortsov SV; Lytsar' BN; Khomenko LP
    Akush Ginekol (Mosk); 1993; (4):48-50. PubMed ID: 8250120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Utility of CA19-9 and CEA as tumor marker in colorectal cancer--comparison between serum level and distribution].
    Okuda K; Kodaira S; Watanabe M; Takami H; Teramoto T; Abe O; Iri H; Ino Y; Hirohashi S
    Nihon Gan Chiryo Gakkai Shi; 1986 Jun; 21(5):969-77. PubMed ID: 3463631
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
    Kimura E; Murae M; Koga R; Odawara Y; Nakabayashi Y; Yokoyama K; Nakata H; Totake T; Ochiai K; Yasuda M
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Nov; 36(11):2121-8. PubMed ID: 6595320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.